UK Breast Cancer Consultants

Dr Shaun Tolan is  a Consultant Oncologist based at The Clatterbridge Cancer Centre in the Wirral.

Dr Tolan specialises in breast and urological (prostate and bladder) cancers. He has NHS clinica at Clatterbridge and at Warrington and Halton and Arrowe Park Hospitals.  He is a member of the Multidisciplinary Teams for breast cancer at Warrington and Halton, and urology at both Warrington and Halton and Arrowe Park Hospitals.

Dr Tolans specialist training was at The Christie, Manchester and his clinical research fellowship was at the University of Toronto's Department of Radiation Oncology at Princess Margaret Hospital, Toronto.

In private practice he treat patients with breast, prostate and bladder cancers with chemotherapy, hormone therapy and radiotherapy and uses radiotherapy to palliate symptoms from cancer and for the treatment of skin cancers.

Dr Tolan is the Chair of the Medical Advisory Board and therefore has an important role in advising the The Clatterbridge Clinic’s management team on all medical matters relating to the clinic, including clinical governance.

He is a member of the Royal College of Physicians, a Fellow of Royal College of Radiologists (Faculty of Clinical Oncology), British Uro-oncology Group and the British Medical Association.

Dr Shabbir Susnerwala is a Consultant Clinical Oncologist based at The Rosemere Cancer Centre at the Royal Preston Hospital.

Dr Susnerwala qualified in oncology at Bombays largest cancer hospital, the Tata Memorial Hospital and was appointed as a consultant oncologist in 1989. He decided to move to the UK in 1992 and joined Europe's largest cancer centre, The Christie Hospital, Manchester where he consolidated his oncological experience. In 1996 he was appointed as Consultant Clinical Oncologist at the newly established Rosemere Cancer Centre.

He specialises in the treatment of Colorectal, Breast and Urological cancers. His expertise have been widely sought for many years both in clinical practice and education and he has held a number of positions that reflect this. These include Clinical Director for Oncology Services, Educational Supervisor, College Tutor (Royal College of Radiologists), Overseas Doctors Mentor, Member of Postgraduate Committee (Royal Preston Hospital), Audit Lead for Oncology,  Lead Cancer Clinician for Lancashire Teaching Hospital chain and is a member of the Clinical Governance Committee for Oncology.

Dr Susnerwala is a member of The Royal College of Radiologists and speaks English, Gujarati and Hindi.

Dr Sarah Harris is a Consultant Clinical Oncologist based at Guy's and St Thomas' NHS Foundation Trust in London.

Dr Harris trained in clinical oncology as a specialist registrar in Poole and Southampton and as a senior registrar at St Bartholomews Hospital. She spent 2 months in the USA looking at advanced radiotherapy techniques before becoming a consultant clinical oncologist at Guy's and St Thomas'. 

Dr Harris has been a Consultant at Guy's and St Thomas' since 1998. She specialises in the treatment of breast and prostate cancers using drug therapy and radiotherapy. She has a special interest in the use of advanced radiotherapy techniques to deliver the best quality treatment while minimising the side effects to the patient. This allows the external radiotherapy used in breast cancer to avoid the heart and other important structures.

Dr Harris is part of the multi-disciplinary team Guys and St Thomas, which assesses patients’ suitability for intra-operative radiotherapy . This is given as a single treatment to the breast in some patients and may avoid a longer course of external radiotherapy. Dr Harris has trained in treatment of breast and urological cancers using radiotherapy and drug therapies including hormone treatments and chemotherapy and targeted therapies. She is trained in the use of advanced radiotherapy techniques including IMRT and cyberknife with breast cancer and advanced radiotherapy techniques including IMRT , IGRT and cyberknife for urological cancer treatments.

Dr Harris has had many papers published in peer review journals and books, on the management of breast and urological cancers. She is a member of Royal College of Radiologists and Royal College of Physicians

Dr Martin Hogg is a Consultant Clinical Oncologist based at The Cancer Centre at Royal Preston Hospital (Lancaster Teaching Hospitals NHS Foundation Trust).

Dr Hogg qualified from Oxford University in 1990 having developed a particular interest in Oncology. In additional to his medical studies, he took a degree in physiological sciences specialising in cellular physiology, biology and immunology as well as undertaking some undergraduate research work developing a novel technique for assessing reflux of ions across cell membranes. He continued his medical studies at St Bartholomews Medical School in London qualifying in 1993 as a doctor from the University of London. 

Continuing in Oncology, his first position was in the field of leukaemia and lymphoma working under Professor Rohitiner and Professor Lister at Barts, London. Following general medical training as a Senior House Officer in the Leicestershire rotation he moved to the Christie Hospital in Manchster as a Specialist Registrar in Oncology.

During his time at the Christie he obtained a wealth of experience in treating all tumours using the treatment modalities of radiotherapy and chemotherapy. During his time, he undertook some research including phase one research for new chemotherapy treatment regime in colorectal cancer and in the management of central lines. He has had abstracts presented at the American Society of Clinical Oncology (ASCO) Meeting and has co-authored a chapter on the management of cancer of the stomach. 

In the latter part of his training he developed a particular interest in breast and gynaecological malignancies. 

He was appointed Consultant at the Rosemere Cancer at Royal Preston Hospital in 2003 and was closely involved in the reconfiguration of the management of breast and gynaecological malignancies.

He is continuing to work to improve the standards of oncological care in those areas addressing issues that are reflected in the North West Cancer Plan and the Cancer Reform strategy such as developing the provision of local administration for chemotherapy, as close to the patients home as possible and access to high quality image guided radiotherapy. 

He is currently Lead Clinician for breast cancer at the Rosemere Cancer Centre and Clinical Director of the centre. He has also been Chair of the Breast Cancer Network Site Specific Group for many years. In addition to the standard clinical roles he has run a conference for numberous years, for Breast Care Nurses in the North of England, offering updates and education. 

He has worked closely with Dr Louise Foreman, a palliative care consultant colleague and has set up a National palliative Care Conference aimed at providing an Oncological update for palliative care consultants and specialist registrars. 

Dr Hogg also leads Lancashire and South Cumbria Network in the Tri-network Meetings along with the Mersey and Greater Manchester groups and in 2008 organised and chaired the Tri-Network Meeting.

He Speaks two Languages, English and French and has been Awarded a Undergraduate Orthopedics Prize.

Dr Joanna Gale is a Consultant Medical Oncologist based at The Portsmouth Hospitals NHS Trust.

Dr Gale treats urological cancers and breast cancer. She trained in Batchelor of Medicine at Southampton University Medical School in 1990 and Doctor of Medicine Southampton University in 2001.

Dr Gale is a member of the Royal College Physicians and a Fellow Royal College Physicians.

Dr Jeremy Braybrooke is a Consultant Medical Oncologist at University Hospitals Bristol NHS Foundation trust.

Dr Baybrook completed his undergraduate training at Southampton University and in Medical Oncology at the Cancer Research UK Medical Oncology unit in Oxford. During this time he completed a PhD, supervised by Professor Adrian Harris and Professor Ian Hickson, studying DNA damage and repair. He was appointed to his current consultant post in Bristol in 2003 and has developed a large patient focused clinical practice and is passionate about clinical research and improving patients' experience of chemotherapy treatments. He is actively involved in fund-raising for 'Above and Beyond' and 'It's in the Bag' charities improving awareness of testicular cancer.

Dr Braybrooke has been a member of the NICE Lung Cancer Clinical Guideline Development Group and currently sits on a NICE Technology Appraisal Committee evaluating new medicines. He is also a member of the American Society of Clinical Oncology, and was a member of the National Cancer Research Network Testicular Cancer Clinical Studies Group (2005 - 2010) and was Chair of Avon Somerset and Wiltshire Cancer Network Breast Cancer Site Specific Group (until April 2010)

Mr Ashu Gandhi is a Consultant Surgeon based at the Nightingale & Genesis Breast Cancer Prevention Centre, a recognised centre of excellence based at the University Hospital of South Manchester.

This is one of the largest Breast Units in the UK and also one of the busiest breast screening units, receiving referrals from across Greater Manchester and the North West. 

Mr Gandhi is Quality Assurance Surgeon for the North West Breast Screening Quality Assurance team which acts to ensure consistent and high standards of care for women undergoing breast screening in the region. He sits on the Audit & Screening Committee for the Association of Breast Surgery. In addition Mr Gandhi is a member of the Breast Cancer Family History service at the Nightingale & Genesis Centre and member of the Medical Board of The Genesis Breast Cancer Prevention Charity. 

Mr Gandhi is also fully trained and accredited in Thyroid and Parathyroid Surgery. He runs a busy Endocrine Surgery practice at University Hospital of South Manchester and is a core member of the Greater Manchester & Cheshire Thyroid Cancer Team. He is Secretary for the British Association of Endocrine & Thyroid Surgeons and has contributed on their behalf to the British Thyroid Association treatment guidelines.

Mr Gandhi is a member of the Association of Breast Surgery and the British Association of Endocrine & Thyroid Surgeons.

Professor Gerard Byrne is a Consultant Oncoplastic and Aesthetic Breast Specialist Surgeon based in Manchester.

He has been an established Specialist in this field for more than 10 years. He is one of the most experienced and respected Breast Surgeons in the North of England preforming breast cancer and breast reconstruction operations, breast augmentations and breast reductions and symptomatic and cosmetic breast procedures. 

Professor Byrne is a clinical academic surgeon working in the field of breast surgery. As a medical educationalist, he held a number of senior administrative and leadership roles including Hospital Dean for Clinical Studies, and most recently Director of the University Hospital of South Manchester Health education Academy.

He has lead the development of this academy from its inception working in partnership with numerous internal and external public and private stakeholders.  The Academy has focused on a social responsibility strategy which has led to the development of strong local, national and international collaborations. He passionately believes in the strength of the team over the individual and is driven by encouraging others to achieve to their maximum ability. In recognition of his contribution to healthcare education, he was awarded a National Teaching Fellowship; recognised as the highest UK award for education within the higher education community. He recently played a substantial part in the creation of the Greater Manchester Health Innovation and Education Cluster.

Professor Byrne is best known as the director and co-founder of the Universities Medical Assessment Partnership (UMAP) - a partner-funded collaboration of 15 medical schools which develops high quality assessment items for medical examinations. 

Dr Elaine Young is a Consultant Clinical Oncologist based at The Rosemere Cancer Centre at Royal Preston Hospital.

Dr Young qualified from the University of Liverpool in 1988 and gained considerable experience in the field of oncology. She went on to a two year Senior House Officer rotation in general medicine in Liverpool and one year as a Medical Registrar in North Wales. Dr Young first worked in oncology with Trevor Powles at the Royal Marsden Hospital and Undertook Registrar training in clinical oncology at the Christie Hospital in Manchester, before joining the Royal Preston Hospital in 2000 as a Consultant Oncologist, specializing in Breast Cancer, Upper GI Cancer, Chemotherapy & Radiotherapy.

Dr Youngs specialises in Clinical Oncology involving the use of chemotherapy, radiotherapy, endocrine and targeted therapies in the treatment of malignant conditions. She enjoys teaching and is currently involved in the development of undergraduates and postgraduates.

She was Awarded the Henry Briggs memorial medal, in 1998 and the Red Rose Hero award, in 2007.

Dr Andrew Hindley is a Consultant Clinical Oncologist based at The Cancer Centre at Royal Preston Hospital.

Dr Hindley qualified at Birmingham University Medical School in 1977, having been on a travelling scholarship to Malaysia. His elective was spent in oncology at the University of Heidelberg. After training in General Medicine he worked at the Christie Hospital in Clinical Pharmacology, learning how to use anti-cancer drugs, safely and effectively, and carried out research into hormone therapy of breast cancer. He then underwent training in radiotherapy and first became a Consultant in New Zealand prior to taking up his current consultant appointment at Royal Preston Hospital in 1997. 

His clinical interests are in breast cancer, lung cancer, gynaecological, central nervous system and skin cancer. He is actively involved in research into new treatments and training medical students and junior doctors.

His publications have covered hormone therapy and breast cancer, radiotherapy for gynaecological cancer and head and neck cancer, and chemotherapy for gynaecological cancer. His clinical interests are in breast cancer, lung cancer, gynaecological, central nervous system and skin cancer.

In addition to his clinical role Dr Hindley is the Network Clinical Lead for Research and is committed to improving cancer treatment and supportive care for patients in clinical trials. His particular research interests include chemotherapy for platinum resistant disease in ovarian cancer, overcoming unwanted effects of radiotherapy and development of new treatments for brain tumours.